Navigation Links
Do our medicines boost pathogens?
Date:12/21/2011

against the drug, but also resists better to the macrophages of its host. Macrophages are important cells of our immune system.

There is no absolute proof yet (among other things, because one obviously cannot experiment on humans) but everything suggests that resistant Leishmania not only survive better in humans have a higher "fitness" but also are better at making people ill have a higher "virulence" than their non-resistant counterparts.

Superbug?

It is the first time that science finds an organism that always benefits from its resistance. Normally resistance is only useful when a pathogen is bombarded by drugs; the rest of the time it is detrimental to the organism.

Resistant organisms are a real problem to medicine. More and more pathogens become resistant to our drugs and antibiotics to a large extend because you and I use them too lavishly and improperly. For several microbes, the arsenal of available drugs and antibiotics has so diminished that people may die again from pneumonia, or even from ulcerating wounds.

Luckily for us, resistance helps pathogens only in a drug-filled environment. In the open field their resistance is a disadvantage to them, because they have to invest energy and resources into a property with no use there. Just like a suit of armour is quite useful on the battle field, but a real nuisance the rest of the time.

So the propagation of resistant organisms is substantially slowed down because they are at a disadvantage outside of sick rooms. But this rule, too, is violated by Leishmania: even in absence of the drug, the resistant parasite survives better, instead of worse, and it is more virulent than a non-resistant parasite.

Did our medicines create a superbug? A legitimate question, and the phenomenon has to be investigated, but this sole case doesn't imply we better stop developing new medicines (as a matter of fact, the antimony-resistant Leishmania are still suscep
'/>"/>

Contact: Jean-Claude Dujardin
jcdujardin@itg.be
32-324-76358
Institute of Tropical Medicine Antwerp
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. First study to reveal how paracetamol works could lead to less harmful pain relief medicines
2. Scripps Health/the Medicines Company announce late breaking BRIDGE trial results presented at TCT
3. Clinical tests for medicines made from genetically modified plants
4. Medicines from plants
5. Accelerated lab evolution of biomolecules could yield new generation of medicines
6. Sunlight can influence the breakdown of medicines in the body
7. New treaty on search for life-saving medicines in remote areas
8. 40-year-old test procedure finds modern niche in developing new medicines
9. Reducing gene-damaging impurities in medicines
10. Problem of fake medicines in developing countries could be solved
11. Insight into cells could lead to new approach to medicines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Do our medicines boost pathogens?
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform ... State of Washington,s Department of Licensing, in the ... issuance system for driver,s licenses and identification cards to its ... development will start in January 2015, with enrollment and card ...
(Date:1/22/2015)... Wis. , Jan. 15, 2015  BellBrook Labs, ... drug discovery, announced the launch of a TR-FRET ... the company,s Transcreener UDP Assay, a high throughput ... The new assay will allow for sensitive detection ...
(Date:1/22/2015)... Report Issued by Small Cap IR. In 2011, Nilson Report,s ... at merchants on the leading payment cards rose to $135.3 ... and prepaid cards reached 6.54 billion.  Eight million credit card ... in 2012, and credit and debit card fraud resulted in ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... and the hundreds of microbial communities that lurk in ... the Society for General Microbiology,s autumn meeting in Nottingham ... 6-9 September at the Jubilee Campus, University of Nottingham. ... research covering a wide range of modern microbiology from ...
... new research from North Carolina State University shows that a ... past 3,000 years has actually increased in size, despite ... area. "What we,ve found indicates that human activity does ... negative impact on a species even a species that ...
... , A tiny marine filter-feeder, that anchors itself to the ... of the West Antarctic Ice Sheet a region that ... part of a study for the Census of Antarctic Marine ... colonies of bryozoans from coastal and deep sea regions around ...
Cached Biology News:Archaeological study shows human activity may have boosted shellfish size 2Marine animals suggest evidence for a trans-Antarctic seaway 2
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 ... technologies such as the Bioruptor® and complete solutions ... system for chromatin immunoprecipitation, alleviating the need for ... and controls needed for ChIP of histones or ...
(Date:1/22/2015)... Jan. 22, 2015   GenoSpace , a precision medicine software ... enable the broad use of genomic, imaging and other biomedical ... of Michelle Munson , CEO of Aspera, an IBM ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We are ...
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 ... patient care in critical areas, announced the closing of an ... warrants to purchase up to an aggregate 3,500,000 shares of ... and $.01 per warrant.  The warrants have a per share ...
(Date:12/24/2014)... St. Louis, Missouri (PRWEB) December 23, 2014 ... Swiss biotechnology company, Syngenta, are in the process of being ... consolidated case is In Re: Syngenta AG MIR 162 Corn ... the District of Kansas. , Management of the Syngenta GMO ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
... - Reflects Strong International Growth and Successful ... Firm , CPA Global, the world,s ... leading provider,of outsourced legal support services, has today marked its ... , Founded in 1969 as a ...
... Meeting to Enable Stockholders to Determine Fate of ... Offers Avigen Stockholders Extraordinary Risk/Reward OpportunitySAN FRANCISCO, Jan. ... its affiliates ("BVF") today announced that it has ... Inc. ("Avigen") (Nasdaq: AVGN ) call ...
... - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, ... Finance Forum on Tuesday, January 13, 2009 in San ... , Dr. Randal Chase, president and CEO of ImmunoVaccine ... the development of its superior vaccine delivery system, DepoVax(TM). ...
Cached Biology Technology:CPA Global Marks 40th Anniversary With Launch of New Brand 2CPA Global Marks 40th Anniversary With Launch of New Brand 3Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 2Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 3Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 4Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 5
SNARE associated protein snapin, clone MGC:2717...
Human Serpin A8/AGT Affinity Purified Polyclonal Ab Keywords: Ang II, AngII, Hypertension, Salt Homeostasis, Pre-eclampsia...
Human/Mouse G9a/EHMT2 MAb (Clone A8620A) Keywords: Eu-HMTase2...
Mouse GDF-8 Propeptide Affinity Purified Polyclonal Ab...
Biology Products: